Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia

Documenti analoghi

• Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
  di: Mettananda, Sachith, et al.
  Pubblicazione: (2019)
• α-Globin as a molecular target in the treatment of β-thalassemia
  di: Mettananda, Sachith, et al.
  Pubblicazione: (2015)
• Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
  di: Mettananda, Sachith, et al.
  Pubblicazione: (2017)
• A Cell-Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1
  di: Schiller, Rachel, et al.
  Pubblicazione: (2014)
• A Miniaturized Screen for Inhibitors of Jumonji Histone Demethylases
  di: Sakurai, Masaaki, et al.
  Pubblicazione: (2009)